RxDoctor Payments Data

Kasie Palmer, PA

Surgical · Las Vegas, NVNPI 1871964676

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.9% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among surgical clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,309in general payments, 2019–2025

Across 356 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$933
  • Sanofi$878
  • Incyte Corporation$726
  • Lilly USA, LLC$597
  • UCB, Inc.$522
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$7,72193%
  • Education$5877%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,309 in reported general payments places this provider in the 95th percentile of 91 surgical providers in Nevada.

See all surgical providers in Nevada

Medicare billing

Part B allowed, 2024
$369,020
Medicare patients
478
Services billed
4,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$57,527
Tacrolimus21$2,441
Ciclopirox38$1,152
Metronidazole17$864
Triamcinolone Acetonide80$730
Ketoconazole56$713
CiclopiroxCiclopirox Olamine35$700
Doxycycline Hyclate29$489
Fluocinonide20$471
Clobetasol Propionate12$361
Hydroxyzine Hcl36$360
Betamethasone Dipropionate14$296
Hydrocortisone33$159
Mupirocin12$72
Methylprednisolone12$57

Paid to pharmacies, not to this prescriber.

Other surgical in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →